Both human biovars of Chiamydia trachomatis were able to productively infect primary cultures of fetal rat brain cells. Infected brain cells released bacteria that reinfected McCoy ceUs as wel as other cultured brain cells. The chlamydiae infected cultured astrocytes but were never observed to grow inside neurons, suggesting a selective susceptibility of specific brain cells to chlamydial infections.
Both human biovars of Chiamydia trachomatis were able to productively infect primary cultures of fetal rat brain cells. Infected brain cells released bacteria that reinfected McCoy ceUs as wel as other cultured brain cells. The chlamydiae infected cultured astrocytes but were never observed to grow inside neurons, suggesting a selective susceptibility of specific brain cells to chlamydial infections.
Chlamydia trachomatis is a pathogenic bacterium that causes a wide array of human diseases (18) and, in some instances, is associated with indolent infections in target tissues. Although C. trachomatis can bind to various cell types (2, 3) . The production of infectious organisms, which involves the successful binding, ingestion, replication, and release of bacteria, occurs primarily in fibroblast and epithelial cells (6, 11, 21) .
The central nervous system is susceptible to several types of virus infections which can initiate degenerative effects with remarkable regional specificity (7) . Although some evidence suggests that chlamydiae can be a cause of encephalomyelitis (13, 20) , the ability of these bacteria to infect central nervous system cells or the specific cell populations which may be vulnerable has yet to be demonstrated. We therefore examined whether two biovars of C. trachomatis reacted with fluorescein-conjugated mouse monoclonal anti-L2 or anti-genus-specific antibody, respectively (generously provided by M. Tam, Genetic Systems, Seattle, Wash.) (19) . Cover slips incubated with anti-genus-specific antibody were washed and then reacted with fluorescein-conjugated goat anti-mouse immunoglobulin G (IgG) (2) . Astroglial, neuronal, and fibroblast phenotypes were identified in double immunofluorescence staining experiments. Following immunolocalization of the bacteria, cover slips were subjected to the following treatment: (i) incubation with rabbit antiglial fibrillary acidic protein (GFAP; generously provided by L. F. Eng, Veterans Administration Medical Center, Palo Alto, Calif. [8] ) for 3 h at 370, extensive washing, and subsequent incubation with rhodamine-conjugated swine anti-rabbit IgG to detect astrocytes; (ii) incubation with culture supernatant containing monoclonal antibody to mouse neurofilament protein [IgM(K) recognizing the 200-and 150-kilodalton doublet; E. Pawlak-Byczkowska and P. Levitt, Neuroscience, 11:1212 ] and then rhodamineconjugated goat anti-mouse IgG(,u) to detect neurons; and (iii) incubation with rabbit anti-human fibronectin and then rhodamine-conjugated swine anti-rabbit IgG to detect fibroblasts. Control incubations consisted of fluorescein-conjugated mouse IgG (MOPC-21) or IgM (MOPC-104E), normal rabbit serum, and rhodamine-conjugated swine anti-rabbit IgG. Under these conditions, background staining was negative.
At 48 h after infection with 10 ID50 of the L2 or B strain of C. trachomatis, cells and culture media were harvested separately. Cells were washed twice with phosphate- (8, 19) . Astrocytes were stained with rabbit anti-GFAP antibodies, neurons were stained with monoclonal antibody to mouse neurofilament protein, and fibroblasts were stained with rabbit anti-human fibronectin antibodies.
A large number of cells that possessed inclusions also contained GFAP; approximately 50% of inclusions produced by both the L2 (data not shown) and B (Fig. 1) strains were found predominantly in GFAP-positive cells; conversely, almost 50% of inclusion-containing cells did not react with anti-GFAP antibodies. The sizes of the inclusions varied greatly, suggesting the presence of developmental heterogeneity.
We analyzed whether GFAP-negative, inclusion-containing cells were fibroblasts by costaining brain cell cover slips with antichlamydia and antifibronectin antibodies (Fig. 2) . Fibroblast contamination of cultures varied from 0.5 to 2%; while some fibronectin-positive cells exhibited inclusions (approximately 30%), these cells were maximally able to account for fewer than 1% of chlamydia-infected brain cells.
To determine whether neurons were infected by chlamydiae, we stained cover slips with antichlamydia and antineurofilament antibodies. Although over 106 cells were scanned, not a single infected neuron could be identified in cultures containing 10 to 20% infected cells and up to 50% stained neurons. These data strongly suggest that astroglial cells and not neurons can be infected by C. trachomatis in vitro, thereby producing and subsequently releasing infectious bacteria.
Our results demonstrate that both biovars of C. trachomatis can enter, grow in, reproduce in, and release infectious progeny from primary cultures of normal brain cells. The data show that chlamydiae invade and replicate in rat brain astrocytes in vitro, raising the possibility (but not directly demonstrating) that such cells may be able to serve as hosts if exposed to these bacteria in vivo, similar to the situation observed with Toxoplasma gondii-infected astrocytes (10) .
Astroglial cells, once regarded as nonspecialized structural supports for neurons in the central nervous system, appear to carry out important functions in both the developing (12) and the mature (9) brain. Developing astrocytes are intimately associated with the ventricular system and brain vasculature prior to blood-brain barrier formation. In the mature brain, astrocytes are present in large numbers in regions lacking a blood-brain barrier, such as the circumventricular organs, as well as exhibiting characteristic investments of endothelial cells in brain capillaries. The specific distribution of developing and mature astrocytes in these areas makes them potentially susceptible to bloodborne chlamydiae, which have been shown to infect several organs in mice after in vivo immunization (4).
Neurons are not infected by chlamydiae in brain cell cultures. Although chlamydiae may adhere to neuronal cell bodies and axons in vitro, they cannot enter neuronal cells. This finding is not unusual, since it has been shown that other cell types, such as B lymphocytes and certain leukocyte cell lines, bind but do not ingest chlamydiae (2, 3) . More importantly, chlamydiae can stimulate proliferation and differentiation of B lymphocytes to immunoglobulinsecreting cells (1) . Thus, it is conceivable that chlamydiae could alter neuronal function without entering neuronal cells.
The majority of GFAP-negative cells infected by chlamydiae were not fibroblasts. Fibroblast contamination in these on August 27, 2017 by guest http://iai.asm.org/ Downloaded from cultures was always less than 2%, while an average of 12% of cells were infected with chlamydiae. Since 50% of infected cells were GFAP positive and only 30% of fibronectinstained cells possessed inclusions (fewer than 1% of the total cells in culture), the remaining inclusion-containing cells that were GFAP negative probably represented immature (GFAP negative) astroglial cells or oligodendrocytes. A recent study demonstrated that cells derived from the brain, including a cultured human oligodendroglial cell line (KG-1-C) and primary mouse Schwann cells, are capable of phagocytosing mycobacteria (17) . The growth of the bacteria inside these cells was not evaluated.
It is unknown whether the state of glial cell maturation or the particular glial cell type mediates infection by chlamydiae or whether such responses can be modified by agents known to influence chlamydial growth, such as the interferons (5). The development of T. gondii in cultured mouse brain astrocytes can be modified by exposing cells to gamma interferon at different times (10), a situation that potentially could exist for chlamydiae, too. In view of the role of astrocytes in regulating numerous developmental and homeostatic processes in the brain (9), the apparent vulnerability of both immature (early in culture) and mature (late in culture) astrocytes to chlamydial infections may have important consequences.
